These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7278927)

  • 21. Prediction of response to bromocriptine in acromegaly.
    Atkinson AB; Trimble ER; Hadden DR; Sheridan B
    Ulster Med J; 1978; 47(1):73-8. PubMed ID: 653899
    [No Abstract]   [Full Text] [Related]  

  • 22. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term therapy of acromegaly and gigantism by using CB-154].
    Aizawa T; Tawada M; Koizumi Y; Ikejiri K; Kotani M
    Horumon To Rinsho; 1977 Dec; 25(12):1310-5. PubMed ID: 598032
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical use of CB-154 in acromegaly (author's transl)].
    Demura R
    Horumon To Rinsho; 1979 May; 27(5):495-504. PubMed ID: 455758
    [No Abstract]   [Full Text] [Related]  

  • 25. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 26. Bromocriptine and acromegaly: therapeutic implications.
    Brooks AP; Stephen PJ; Nairn IM; Strong JA
    J R Soc Med; 1979 Aug; 72(8):562-4. PubMed ID: 552555
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of parlodel on carbohydrate metabolism regulation in acromegaly].
    Molitvoslovova NN
    Sov Med; 1984; (1):24-9. PubMed ID: 6701649
    [No Abstract]   [Full Text] [Related]  

  • 28. Acromegaly--results of long term treatment with bromocriptine.
    Besser GM; Wass JA; Thorner MO
    Acta Endocrinol Suppl (Copenh); 1978; 216():187-98. PubMed ID: 347861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CB-154 in the treatment of acromegaly: conclusion].
    Shizume K; Demura R
    Horumon To Rinsho; 1977 Dec; 25(12):1349-53. PubMed ID: 598044
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of acromegaly.
    Lamberts SW; Klijn JG; De Lange SA; Birkenhäger JC
    Neth J Med; 1979; 22(5):161-6. PubMed ID: 388245
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effectiveness of using Parlodel in acromegaly].
    Vasiukova EA; Pisarskaia IV; Zefirova GS; Ibragimova GV
    Klin Med (Mosk); 1979 Aug; 57(8):22-4. PubMed ID: 502407
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of CB 154 in the treatment of acromegaly in France (author's transl)(proceedings)].
    Bricaire H
    Ann Endocrinol (Paris); 1976; 37(4):305-8. PubMed ID: 1037363
    [No Abstract]   [Full Text] [Related]  

  • 33. Bromocriptine in the medical management of acromegaly.
    Besser GM; Wass JA; Thorner MO
    Adv Biochem Psychopharmacol; 1980; 23():191-8. PubMed ID: 6249090
    [No Abstract]   [Full Text] [Related]  

  • 34. Bomocriptine treatment of patients with acromegaly resistant to conventional therapy.
    Pelkonen R; Ylikahri R; Karonen SL
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):219-24. PubMed ID: 6993053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of acromegaly with decreased GH levels in the serum by the treatment of either metoclopramide or the combination with CB-154 (author's transl)].
    Naito T; Nakamura T; Suzuki H; Kasai K; Shiina H
    Horumon To Rinsho; 1980 Sep; 28(9):1026-30. PubMed ID: 7460352
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug therapy: Bromocriptine.
    Parkes D
    N Engl J Med; 1979 Oct; 301(16):873-8. PubMed ID: 384250
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutical effects of bromocriptine in 10 acromegalic patients: study of somatotrophic function and glucose tolerance test (author's transl)(proceedings)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA
    Ann Endocrinol (Paris); 1976; 37(4):299-300. PubMed ID: 1037360
    [No Abstract]   [Full Text] [Related]  

  • 38. No effect of treatment with sodium valproate on plasma growth hormone in bromocriptine unresponsive acromegaly.
    Nortier JW; Croughs RJ; Schwarz F; Thijssen JH
    Acta Endocrinol (Copenh); 1986 Feb; 111(2):162-4. PubMed ID: 3082095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bromocriptin treatment of acromegaly (author's transl)(proceedings)].
    Bricaire H; Strauch G; Boutonnat Y
    Ann Endocrinol (Paris); 1976; 37(4):301-2. PubMed ID: 1037361
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of bromocriptine to alter the qualitative characteristics of human growth hormone in acromegaly.
    Hizuka N; Hendricks CM; Roth J; Gorden P
    Metabolism; 1984 Jun; 33(6):582-4. PubMed ID: 6727657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.